followingModerna (Moderna) announced that it will begin a phase 2 clinical trial in the development of a COVID-19 vaccine. that is specific to covid omicron in particular After the participants were vaccinated
Recently, Dr. Anan Chongkaewwatana, a biotech virologist, posted a message. Anan Jongkaewwattana Revealing the results of the vaccine Version 2 of “Moderna“, which is a formula called Bivalent, which is the sum of the spike ohms. add together with Spike of the original vaccine Call this new vaccine mRNA-1273.214 using a dose of 50 micrograms, or half the usual Moderna dosage.
